bpc-157 human clinical trials safety data is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that “healing” biology is not always simple in people with cancer Heal or Harm: Body Protective
Description
It is increasing levels of VEGF to increase angiogenesis
This treatment can lead to redness, burning and blistering, particularly if dosage is not correctly controlled
Dysfunction in the ENS has been linked to a range of gastrointestinal disorders, including irritable bowel syndrome, gastroparesis, and inflammatory bowel diseases
Keep in original sealed packaging
